Earnings
DNOW
16.57
+1.28%
0.21
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2024
2.37B
2.37B
--
1.83B
540.00M
427.00M
399.00M
--
10.00M
--
18.00M
--
113.00M
--
--
1.00M
114.00M
32.00M
82.00M
1.00M
--
--
81.00M
--
81.00M
0.00
81.00M
81.00M
--
81.00M
107.00M
0.76
0.76
--
0.94
FY 2023
2.32B
2.32B
--
1.79B
535.00M
395.00M
389.00M
--
6.00M
--
0.00
--
140.00M
--
--
-2.00M
138.00M
-110.00M
248.00M
1.00M
--
--
247.00M
--
247.00M
-4.00M
243.00M
243.00M
--
243.00M
108.00M
2.25
2.25
--
2.25
FY 2022
2.14B
2.14B
--
1.63B
506.00M
375.00M
361.00M
--
4.00M
--
10.00M
--
131.00M
8.00M
--
--
139.00M
10.00M
129.00M
1.00M
--
--
128.00M
--
128.00M
--
128.00M
128.00M
--
128.00M
111.00M
1.15
1.15
--
1.24
FY 2021
1.63B
1.63B
--
1.27B
357.00M
348.00M
336.00M
--
5.00M
--
7.00M
--
9.00M
--
--
3.00M
12.00M
7.00M
5.00M
--
--
--
5.00M
--
5.00M
--
5.00M
5.00M
--
5.00M
110.00M
0.05
0.05
--
0.07
FY 2020
1.62B
1.62B
--
1.33B
292.00M
712.00M
385.00M
--
6.00M
--
321.00M
--
-420.00M
-10.00M
--
--
-430.00M
-3.00M
-427.00M
--
--
--
-427.00M
--
-427.00M
--
-427.00M
-427.00M
--
-427.00M
109.00M
-3.92
-3.92
--
-2.00

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.